As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping the future of aging research.
Ok so, the parabiosis was a temporary effect, but the answer turned out to be having a blood transfusion with yourself instead. So if this video is right there is a molecule called HMGB1 which can be blocked rather than having said transfusion.
Scientists may have identified one of the molecules that helps aging spread through the body.
Block HMGB1 in mice → less inflammation, better muscle regeneration, improved tissue repair.
The next wave of longevity therapies may focus on stopping aging signals, not just repairing the damage.
Hepatitis C virus infection affects over 58 million individuals and is responsible for 290,000 annual deaths. The infection spread in the past via blood transfusion and iatrogenic transmission due to the use of non-sterilized glass syringes mostly in developing countries (Cameroon, Central Africa Republic, Egypt) but even in Italy. High-income countries have achieved successful results in preventing certain modes of transmission, particularly in ensuring the safety of blood and blood products, and to a lesser extent, reducing iatrogenic exposure. Conversely, in low-income countries, unscreened blood transfusions and non-sterile injection practices continue to play major roles, highlighting the stark inequalities between these regions. Currently, injection drug use is a major worldwide risk factor, with a growing trend even in low- and middle-income countries (LMICs). Emerging high-risk groups include men who have sex with men (MSM), individuals exposed to tattoo practices, and newborns of HCV-infected pregnant women. The World Health Organization (WHO) has proposed direct-acting antiviral (DAA) therapy as a tool to eliminate infection by interrupting viral transmission from infected to susceptible individuals. However, the feasibility of this ambitious and overly optimistic program generates concern about the need for universal screening, diagnosis, linkage to care, and access to affordable DAA regimens. These goals are very hard to reach, especially in LMICs, due to the cost and availability of drugs, as well as the logistical complexities involved. Globally, only a small proportion of individuals infected with HCV have been tested, and an even smaller fraction of those have initiated DAA therapy. The absence of an effective vaccine is a major barrier to controlling HCV infection. Without a vaccine, the WHO project may remain merely an illusion.
Further Reading.
Thumbnail image credit: Not alive, but not dead… FEATURED SCIENCE ARTICLE.
MRI image: Britannica: brain.
anatomy.
Not alive, but not dead: disembodied human brains used for drug testing.
https://www.science.org/content/artic…
Restoration of brain circulation and cellular functions hours.
https://pubmed.ncbi.nlm.nih.gov/30996…
Science #explained #brains #organoid #sciencenews
Healthy sleep and regular exercise can work to counteract genetic mutations in white blood cells that are associated with cardiovascular disease and are most common among older people, Mount Sinai researchers have found. In a study published in Nature, the team reported for the first time that sufficient sleep and exercise can help reduce the cancer-like cell expansion and atherosclerotic risk linked to mutations that spontaneously occur in white blood cells.
These mutations accumulate over our lifetimes and occur most often in hematopoietic stem cells, which are the cells in bone marrow that make blood cells, including macrophages and monocytes, immune cells that help defend the body. When these cells develop mutations, they start to proliferate, multiplying faster than they should, and become more inflammatory, irritating or damaging tissues in the body.
This condition, known as clonal hematopoiesis (CH), is detectable in a quarter of people over age 70 and half of people over 80, the researchers say, though it is infrequent in young, healthy people.
It is an enticing metaphor—implying that experience is literally inscribed in flesh, that the body bears the scars of what the mind cannot face. Yet recent advances in computational and systems neuroscience reveal that this image, while emotionally compelling, is biologically inaccurate. The body proper does not store trauma; the brain dynamically reenacts it through maladaptive inference. What endures after trauma is not a memory lodged in non-innervated tissue but a collapse of flexibility—a loss of metastability, the brain’s ability to fluidly switch among semi-stable network states.
In computational terms, trauma over-weights the precision of danger priors: the brain assigns excessive confidence to threat predictions, constraining inference based on the prior premise of enduring danger. The result is hypervigilance, flashbacks, and avoidance—symptoms of a system caught in self-confirming predictions. Mathematically, this overconfidence means one cannot escape local minima—in a free energy landscape—that become deeply and precisely engrained (i.e., trapped in a ravine with steep sides, where precision corresponds to the local curvature or steepness).
This rigidity contrasts with a healthy brain’s metastable dynamics, where neuronal networks continually integrate and segregate in response to context. This allows neuronal dynamics to explore multiple (unstable) interpretations of the world. Hellyer and colleagues demonstrated that metastability is a hallmark of cognitive flexibility: the capacity for neural coalitions to assemble transiently and adapt quickly. Using both empirical and computational approaches, Hellyer et al. (2015) showed that reduced metastability arising from damage to the structural connectome was associated with diminished cognitive flexibility and impaired information processing. Trauma erodes this fluidity, trapping the brain in narrow basins of fear and defensive salience. To restore mental health is not about ‘releasing’ stored emotion but reestablishing dynamic equilibrium enabling the brain’s ability to move with graceful agility over a landscape of beliefs, commitments and intentions.
A study by UNIGE, in collaboration with ETH Zurich, has significantly improved the accuracy of a noninvasive brain stimulation technique, paving the way for its use in the treatment of neurological and psychiatric disorders.
Brain stimulation techniques can correct abnormal activity in the neural circuits involved in conditions such as Parkinson’s disease and depression. However, current transcranial stimulation methods delivered through the scalp reach only the brain’s surface, limiting their effectiveness. Deep brain stimulation, on the other hand, can target deeper structures but requires surgical implantation of electrodes.
A team from the Synapsy Center for Neuroscience and Mental Health Research at the University of Geneva (UNIGE), in collaboration with ETH Zurich, the Wyss Center Geneva and EPFL, has improved a promising intermediate technology called “temporal interference stimulation.” This method could allow deeper and more targeted noninvasive brain stimulation. The study is published in Cell Systems.
🔒 Stay private online with NordVPN →
https://go.nordvpn.net/SHBMd.
Beat censorship and tracking. 30-day money-back guarantee.
Affiliate link — I earn a small commission at no cost to you.
A major new development in brain-computer technology is raising eyebrows across the tech world. While Elon Musk’s Neuralink has dominated headlines for years, a breakthrough emerging from China is now sparking fresh debate about who is really leading the race to connect the human brain with advanced computing systems.
In this video, we take a closer look at the latest brain-chip innovation, what makes it different from existing neural interface projects, and why experts are paying close attention. As competition intensifies between global technology powers, advances in neural implants could reshape medicine, communication, and even the future relationship between humans and machines.
Could this new achievement challenge Neuralink’s position at the center of the brain-tech conversation? And what does it mean for the future of artificial intelligence, neuroscience, and human enhancement? The implications may be far bigger than many people realize.
Delve into the fascinating world of organoid intelligence at XPANSE 2024 in Abu Dhabi. Presented by Dr. Thomas Hartung, Professor of Medical Microbiology at Johns Hopkins University, this session explores the cutting-edge research and potential of lab-grown organoids to revolutionize computing, medicine, and neuroscience.
XPANSE, the world’s first visioning of the future with exponential technologies, is an Abu Dhabi-based global initiative and an invitation-only forum for exponential technology. XPANSE 2024, hosted by ADQ, convened 3,000 world’s brightest minds, technology trailblazers, Nobel Laureates, industry leaders, CEOs, ministers and scientists to set the horizons of exponential technologies spanning quantum, genomics, exotic computing, embodied intelligence, next-gen 2D matter, AGI, Brain-Machine Interfaces, Future G and beyond.
Be the first one to know about XPANSE 2025 ►► https://mailchi.mp/xpanse.world/sign–… connected with our community & get insider insights ►► / xpanse-world Follow XPANSE on Instagram ►►
/ xpanseworld Follow XPANSE on X ►► https://twitter.com/XPANSEWORLD
Stay connected with our community & get insider insights ►► / xpanse-world.
Follow XPANSE on Instagram ►► / xpanseworld.
Follow XPANSE on X ►►https://twitter.com/XPANSEWORLD